Karnav Modi

Karnav Modi

University of Missouri - Kansas City - Kansas City / United States
Medical and Health Sciences / Internal Medicine
AD Scientific Index ID: 5252296
-
person_outline Karnav Modi's MOST POPULAR ARTICLES
1-) Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionK Rejeski, A Perez, G Iacoboni, V Blumenberg, VL Bücklein, S Völkl, ...Science Advances 9 (38), eadg3919, 2023112023
2-) Etiologies and predictors of 30-Day readmission in Heart failure: an updated analysisA Jain, S Arora, V Patel, M Raval, K Modi, N Arora, R Desai, B Bozorgnia, ...International Journal of Heart Failure 5 (3), 159, 202392023
3-) Utilization of left ventricular assist device for congestive heart failure: inputs on demographic and hospital characterization from nationwide inpatient sampleK Modi, AK Pannu, RJ Modi, SD Shah, R Bhandari, KN Pereira, KT Kubra, ...Cureus 13 (7), 202192021
4-) Simple score of albumin and CRP predicts high-grade toxicity in patients with multiple myeloma receiving CAR-T therapyOS Akhtar, K Modi, J Kim, L Skelson, E Smith, MA Al-Jumayli, ...Transplantation and cellular therapy 30 (3), 283. e1-283. e10, 202462024
5-) Sarcopenia prevalence and influence on the development of toxicity and length of stay in patients with relapsed and refractory myeloma treated with commercial anti-BCMA CART cellsN Parker, K Modi, R Villanueva, L Skelson, A Scotto, M Booth-Jones, ...Blood 140 (Supplement 1), 4688-4690, 202232022